Related Experiment Video

Updated: Aug 22, 2026

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
05:55

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis

Published on: December 1, 2023

The pathogenesis of primary progressive multiple sclerosis: antibody-mediated attack and no repair?

Michael P Pender1

  • 1School of Medicine, Neuroimmunology Research Centre, The University of Queensland, Australia. m.hawes@uq.edu.au

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|September 1, 2004
PubMed

Insights

Primary progressive multiple sclerosis (PPMS) involves diffuse lesions and less remyelination than other MS forms. Autoantibodies may drive disease progression, suggesting B-cell therapies like rituximab as potential treatments.

Area of Science:

  • Neuroimmunology
  • Neurology

Background:

  • Primary progressive multiple sclerosis (PPMS) presents distinct pathological and clinical features compared to relapsing-remitting MS.
  • PPMS lesions are often more diffuse, less inflammatory, and show reduced remyelination potential.
  • Fewer focal brain lesions are typically observed in PPMS.

Purpose of the Study:

  • To differentiate primary progressive multiple sclerosis (PPMS) from other forms of MS.
  • To explore the role of autoantibodies in PPMS pathogenesis.
  • To identify potential therapeutic targets for PPMS.

Main Methods:

  • Comparative analysis of pathological features in different MS subtypes.
  • Investigation of autoantibody involvement in central nervous system (CNS) damage.
  • Review of current understanding of disease mechanisms in PPMS.

Main Results:

  • PPMS lesions are characterized by diffuse pathology and impaired remyelination.
  • Antibodies to CNS antigens are implicated in demyelination, inhibited remyelination, and axonal destruction.
  • The ongoing immune attack and lack of CNS repair contribute to progressive disability in PPMS.

Conclusions:

  • Autoantibodies and B-cell responses are critical factors in PPMS progression.
  • Understanding these responses may lead to improved diagnostic and therapeutic strategies for PPMS.
  • Rituximab, by inducing B-cell apoptosis, represents a potential therapeutic avenue for PPMS.

More Related Videos

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis09:01

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...